Analysts expect Seaport Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | - | - | - | - |
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Seaport Therapeutics, Inc. to report earnings per share of -0.55 for Q3 26, against a range of -0.58 to -0.52. The most recent reported quarter, Q2 26, came in at -1.78, a 201.7% miss against the -0.59 consensus.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -10.34 | -1.78 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -5.50 | -0.56 | -0.52 | -0.55 | -0.61 | -0.62 | 0.19 | -0.05 | -0.47 | 0.11 | ||||||||||
| Low Estimate | -5.84 | -0.62 | -0.58 | -0.61 | -0.67 | -0.68 | 0.15 | -0.05 | -0.51 | 0.09 | ||||||||||
| Consensus Estimate | -5.67 | -0.59 | -0.55 | -0.58 | -0.64 | -0.65 | 0.17 | -0.05 | -0.49 | 0.10 |
Pull Wall Street consensus for Seaport Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SPTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SPTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SPTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();